does glp 1 really work Why GLP-1 Drugs Alone Aren't Enough for Sustainable Weight Loss – STAAR LABS Part 1 of a 3-Part
Description
Medication trials for hyperphagia and food-related behaviors in Prader-Willi syndrome
When you use semaglutide, your GLP-1 receptors experience sustained stimulation
April 24, 2024
Muhammad J
doi: 10.1016/j.cmet.2014.07.012
A retrospective analysis of 105,000+ patients revealed: 40% lower OSA risk with tirzepatide (Zepbound) or semaglutide (Wegovy) vs non-AOM users Lower OSA incidence: 3.12% vs 12.56% Comparable impact between tirzepatide and semaglutide, with tirzepatide showing a slight edge after 6 months This study highlights the potential for AOMs to address obesity and OSA, supporting broader healthcare value through comorbidity reduction
